Variants in exon 11 of MEF2A gene and coronary artery disease: Evidence from a case-control study, systematic review, and meta-analysis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Liu, Yan ^a   Niu, Wenquan ^a   Wu, Zhijun ^a   Su, Xiuxiu ^a   Chen, Qiujin ^a   Lu, Lin ^a   Jin, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; CAG REPEAT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CCA REPEAT; CCG REPEAT; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA STRUCTURE; EXON; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MEF2A GENE; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; RACE DIFFERENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ALLELE; BASE PAIRING; DNA SEQUENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; META ANALYSIS; MIDDLE AGED; RISK FACTOR; TRINUCLEOTIDE REPEAT;

MADS DOMAIN PROTEIN; MEF2A PROTEIN, HUMAN; MYOGENIC FACTOR;

AGED; ALLELES; BASE PAIRING; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; EXONS; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MADS DOMAIN PROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGENIC REGULATORY FACTORS; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84857382287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031406     Document Type: Review

References (48)

1. Topol EJ, Smith J, Plow EF, Wang QK, (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15: R117-123.
2. Yamada Y, Ichihara S, Nishida T, (2008) Molecular genetics of myocardial infarction. Genomic Med 2: 7-22.
3. Hartiala J, Li D, Conti DV, Vikman S, Patel Y, et al. (2011) Genetic contribution of the leukotriene pathway to coronary artery disease. Hum Genet 129: 617-627.
4. Ozaki K, Tanaka T, (2005) Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci 62: 1804-1813.
5. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, et al. (2007) Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 75: 813-820.
6. Iida A, Ozaki K, Ohnishi Y, Tanaka T, Nakamura Y, (2003) Identification of 46 novel SNPs in the 130-kb region containing a myocardial infarction susceptibility gene on chromosomal band 6p21. J Hum Genet 48: 476-479.
7. He M, Guo H, Yang X, Zhang X, Zhou L, et al. (2009) Functional SNPs in HSPA1A gene predict risk of coronary heart disease. PLoS One 4: e4851.
8. Tsantes AE, Nikolopoulos GK, Bagos PG, Vaiopoulos G, Travlou A, (2007) Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: a meta-analysis. Int J Cardiol 118: 189-196.
9. Lusis AJ, (2003) Genetic factors in cardiovascular disease. 10 questions. Trends Cardiovasc Med 13: 309-316.
10. Scheuner MT, (2003) Genetic evaluation for coronary artery disease. Genet Med 5: 269-285.
11. Wang L, Fan C, Topol SE, Topol EJ, Wang Q, (2003) Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302: 1578-1581.
12. Bhagavatula MR, Fan C, Shen GQ, Cassano J, Plow EF, et al. (2004) Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 13: 3181-3188.
13. González P, García-Castro M, Reguero JR, Batalla A, Ordóñez AG, et al. (2006) The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet 43: 167-169.
14. Han Y, Yang Y, Zhang X, Yan C, Xi S, et al. (2007) Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population. Clin Chem Lab Med 45: 987-992.
15. Elhawari S, Al-Boudari O, Muiya P, Khalak H, Andres E, et al. (2010) A study of the role of the myocyte-specific enhancer factor-2A gene in coronary artery disease. Atherosclerosis 209: 152-154.
16. Kajimoto K, Shioji K, Tago N, Tomoike H, Nonogi H, et al. (2005) Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ J 69: 1192-1195.
17. Weng L, Kavaslar N, Ustaszewska A, Doelle H, Schackwitz W, et al. (2005) Lack of MEF2A mutations in coronary artery disease. J Clin Invest 115: 1016-1020.
18. Hsu LA, Chang CJ, Teng MS, Semon Wu, Hu CF, et al. (2010) CAG Repeat polymorphism of the MEF2A Gene is not associated with the risk of coronary artery disease among Taiwanese. Clin Appl Thromb Hemost 16: 301-305.
19. Dai DP, Zhou XY, Xiao Y, Xu F, Sun FC, et al. (2010) Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population. Eur J Clin Invest 40: 669-677.
20. Guella I, Rimoldi V, Asselta R, Ardissino D, Francolini M, et al. (2009) Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease. Circ Cardiovasc Genet 2: 165-172.
21. Hirschhorn JN, Daly MJ, (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6: 95-108.
22. Damani SB, Topol EJ, (2011) Emerging genomic applications in coronary artery disease. JACC Cardiovasc Interv 4: 473-482.
23. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, (2011) Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 377: 383-392.
24. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
25. Patel RS, Ye S, (2011) Genetic determinants of coronary heart disease: new discoveries and insights from genome-wide association studies. Heart 97: 1463-1473.
26. Cohn LD, Becker BJ, (2003) How meta-analysis increases statistical power. Psychol Methods 8: 243-253.
27. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
29. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
30. Einarson TR, McGhan WF, Bootman JL, Sabers DL, (1985) Meta-analysis: quantitative integration of independent research results. Am J Hosp Pharm 42: 1957-1964.
31. Yuan H, Lü HW, Hu J, Chen SH, Yang GP, et al. (2006) MEF2A gene and susceptibility to coronary artery disease in the Chinese people. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31: 453-457 In Chinese.
32. Gulec S, Ruchan Akar A, Akar N, (2008) MEF2A sequence variants in Turkish population. Clin Appl Thromb Hemost 14: 465-467.
33. Lieb W, Mayer B, König IR, Borwitzky I, Götz A, et al. (2008) Lack of association between the MEF2A gene and myocardial infarction. Circulation 117: 185-191.
34. Horan PG, Allen AR, Hughes AE, Patterson CC, Spence M, et al. (2006) Lack of MEF2A Delta7aa mutation in Irish families with early onset ischaemic heart disease, a family based study. BMC Med Genet 7: 65.
35. Dan QH, Lu L, Chen QJ, He RM, (2008) Relationship between CAG repeat polymorphism in exon 11 of MEF2A gene and susceptibility to coronary artery disease. J Diagn Concepts Pract 7: 404-407 In Chinese.
36. Wu D, Li CL, Hu DY, Liu WL, Li L, (2008) The genetic variants of exon 11 of MEF2A gene in patients with acute myocardial infarction. Chinese Journal of Cardiac Pacing and Electrophysiology 22: 144-147 In Chinese.
37. Dai DP, He Q, Zhou XY, Xiao Y, Zhang ZX, et al. (2006) Association of CAG triplet nucleotide repeat in MEF2A with coronary atherosclerotic disease. Chin J Geriatr Heart Brain Vessel Dis 8: 671-674 In Chinese.
38. Maiolino G, Colonna S, Zanchetta M, Pedon L, Seccia TM, et al. (2012) Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family. Eur J Cardiovasc Prev Rehabil In press.
39. Li J, Yang JG, Li W, Du R, Gui L, et al. (2006) Study on novel mutations of MEF2A gene in Chinese patients with coronary artery disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 265-268 In Chinese.
40. Cardon LR, Bell JI, (2001) Association study designs for complex diseases. Nat Rev Genet 2: 91-99.
41. Wang Q, Rao S, Topol EJ, (2005) Miscues on the "lack of MEF2A mutations" in coronary artery disease. J Clin Invest 115: 1399-1400.
42. Altshuler D, Hirschhorn JN, (2005) MEF2A sequence variants and coronary artery disease: a change of heart? J Clin Invest 115: 831-833.
43. Evans D, Aberle J, Beil FU, (2011) The relative importance of common and rare genetic variants in the development of hypertriglyceridemia. Expert Rev Cardiovasc Ther 9: 637-644.
44. Schork NJ, Murray SS, Frazer KA, Topol EJ, (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19: 212-219.
45. Iyengar SK, Elston RC, (2007) The genetic basis of complex traits: rare variants or "common gene, common disease"? Methods Mol Biol 376: 71-84.
46. Polychronakos C, (2008) Common and rare alleles as causes of complex phenotypes. Curr Atheroscler Rep 10: 194-200.
47. De La Vega FM, Bustamante CD, Leal SM, (2011) Genome-wide association mapping and rare alleles: from population genomics to personalized medicine- Session Introduction. Pac Symp Biocomput 2011: 74-75.
48. Panagiotou OA, Evangelou E, Ioannidis JP, (2010) Genome-wide significant associations for variants with minor allele frequency of 5% or less-an overview: A HuGE review. Am J Epidemiol 172: 869-889.